Brivaracetam CAS No. 357336-20-0 Pharmaceutical Intermediates
OVERVIEW
Brivaracetam is a novel antiepileptic drug (AED) that belongs to the racetam family. It is primarily used for the treatment of partial-onset seizures in patients with epilepsy, including those who have not responded adequately to other treatments.
Its unique mechanism of action, which involves selective binding to the synaptic vesicle protein 2A (SV2A). This action helps to stabilize neuronal excitability and reduce seizure frequency.
Physical and Chemical Properties
- Solubility: Soluble in water and organic solvents, facilitating its incorporation into various pharmaceutical formulations.
- Stability: Exhibits good stability under standard laboratory conditions, with a shelf life that allows for extended use without significant degradation.
These properties make Brivaracetam an ideal candidate for incorporation into various pharmaceutical formulations, where stability and solubility are critical for patient compliance and therapeutic effectiveness.
1. Effective Seizure Control: Brivaracetam has been shown to significantly reduce the frequency of partial-onset seizures, providing effective management for patients with epilepsy.
2. Rapid Onset of Action: The drug demonstrates a quick therapeutic effect, allowing for timely relief of seizures and improved quality of life for patients.
3. Minimal Drug Interactions: Brivaracetam has a favorable pharmacokinetic profile, with minimal interactions with other antiepileptic drugs, making it suitable for patients on multiple medications.
4. Ease of Administration: Available in various formulations, including oral tablets and intravenous solutions, Brivaracetam is easy to administer, improving patient adherence to treatment regimens.
As a foreign trade company specializing in pharmaceutical ingredients, we understand the importance of high-quality laboratory instrumentation and consumables in the research and development of Brivaracetam and its applications. Our offerings include:
- High-Performance Liquid Chromatography (HPLC) Systems: Essential for the analysis and quality control of Brivaracetam and its formulations.
- Mass Spectrometers: Used for the precise identification and quantification of Brivaracetam in various formulations.
- Stability Chambers: To assess the stability of Brivaracetam under different environmental conditions, ensuring product reliability.
- Customizable Lab Consumables: We provide a range of lab consumables tailored to meet the specific needs of our clients, ensuring seamless integration into their research processes.
In conclusion, Brivaracetam is a vital compound in the management of epilepsy, particularly for patients suffering from partial-onset seizures.
Its unique physical and chemical properties, combined with its rapid onset of action and minimal drug interactions, make it a preferred choice for healthcare professionals.
By choosing Brivaracetam, you are not only investing in a superior product but also in the health and well-being of patients who rely on effective seizure management.
As a reliable supplier, we are committed to providing high-quality Brivaracetam and supporting laboratory instrumentation to enhance your research and development efforts.Partner with us for timely delivery, exceptional service, and a commitment to quality that you can trust.
Contact us today to learn more about our offerings and how we can support your pharmaceutical needs.